It’s noteworthy here that no significant difference was found when comparing PRSS1 levels in ALL subtypes, T-ALL versus B-ALL patients (206.1(158.6–239.3) and 175.1(151.6–230.3) ng/ml, p = 0.4687) as shown in Supplementary Figure S3. The gene discussed is PRSS1; the disease is acute lymphoblastic leukemia.